STAAR Surgical falls as proxy adviser recommends against revised Alcon deal
Source: SeekingAlpha
2025-12-12 11:24:03 ET
More on STAAR Surgical, Alcon
- STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain
- Alcon: Some Premium Coming Out Of This Quality Play
- Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript
- Alcon draws double downgrade at BofA on earnings growth risk
- STAAR Surgical holder Yunqi Capital still against sale to Alcon
Read the full article on Seeking Alpha
For further details see:
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal
STAAR Surgical Company
NASDAQ: STAA
STAA Trading
3.01% G/L:
$18.12 Last:
582,765 Volume:
$17.62 Open:
STAA Latest News
February 25, 2026 04:01:00 pm
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
STAA Stock Data
$865,509,982
49,244,533
31.2%
72
N/A
Medical Equipment & Supplies
Healthcare
US
Lake Forest
